Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESPRIT: Intensive vs Standard SBP Lowering in High Vascular Risk Patients
NCT04030234Completed
- Sponsor
- National Center for Cardiovascular Disease
- Start
- Sep 2019
- Primary completion
- Jun 2023
- Countries
- 1
01
Overview
Randomised, open-label trial in hypertension (HTN) (2 arms), sponsored by National Center for Cardiovascular Disease. Primary endpoint: Composite of major CVD events at 4 years. Started Sep 2019; status: completed.
02
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT04030234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04030234.